No increased risk of hepatotoxicity in long-term use of nonnucleoside reverse transcriptase inhibitors in HIV-infected patients

B. van Welzen, T. Mudrikova, J.E. Arends, A.I.M. Hoepelman

Research output: Contribution to journalArticleAcademicpeer-review

Fingerprint

Dive into the research topics of 'No increased risk of hepatotoxicity in long-term use of nonnucleoside reverse transcriptase inhibitors in HIV-infected patients'. Together they form a unique fingerprint.

Medicine & Life Sciences

Social Sciences